Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy by Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Emmanuelle Liaudet-Coopman, Pénélope Desroys du Roure, Timothée David, Aude Mallavialle

Get full text

TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS by Cécile Rittore, Déborah Méchin, Elodie Sanchez, Léa Marinèche, Vuthy Ea, Stephan Soler, Marion Vereecke, Aude Mallavialle, Eric Richard, Isabelle Duroux-Richard, Florence Apparailly, Isabelle Touitou, Sylvie Grandemange

Get full text

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. by Nina Fenouille, Mélanie Tichet, Maeva Dufies, Anaïs Pottier, Ariane Mogha, Julia K Soo, Stéphane Rocchi, Aude Mallavialle, Marie-Dominique Galibert, Amir Khammari, Jean-Philippe Lacour, Robert Ballotti, Marcel Deckert, Sophie Tartare-Deckert

Get full text

Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 function. by Jane Muret, Meriem Hasmim, Izabela Stasik, Abdelali Jalil, Aude Mallavialle, Arash Nanbakhsh, Ludovic Lacroix, Katy Billot, Véronique Baud, Jérome Thiery, Philippe Vielh, Philippe Terrier, Joelle Wiels, Lyubomir Vassilev, Axel Lecesne, Sylvie Bonvalot, Salem Chouaib

Get full text

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma by Ilona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, Serena Diazzi, Christopher Rovera, Virginie Prod’homme, Mickael Ohanna, Ana Popovic, Aude Mallavialle, Frédéric Larbret, Sabrina Pisano, Stéphane Audebert, Thierry Passeron, Cédric Gaggioli, Christophe A Girard, Marcel Deckert, Sophie Tartare‐Deckert

Get full text